Four UF researchers receive Florida Breast Cancer Foundation grants
Four UF Health Cancer Institute researchers have received 2026-27 Scientific Research Grants from the Florida Breast Cancer Foundation.
Posts tagged as
Weizhou Zhang
Weizhou Zhang, Ph.D., named co-leader of expanded Immuno-Oncology and Microenvironment research program
Coupled with an expanded programmatic focus on the tumor microenvironment, the continued development and translation of novel immunotherapies will accelerate.
UF Health Cancer Institute announces research program leadership changes
UF Health Cancer Institute announces research program leadership changes.
Researchers develop new drug for aggressive leukemias
Researchers created a drug that effectively kills aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
Study points to new way to activate immune system in kidney cancer
The study could pave the way for a new combination therapeutic strategy in clear cell renal cell carcinoma.
Researchers develop new duo-targeting drugs to treat aggressive acute myeloid leukemia
UF Health Cancer Institute researchers have created a novel drug that shows promise for the treatment of aggressive AML.
Weizhou Zhang, Ph.D., named co-leader of Mechanisms of Oncogenesis research program
The MOO research program aims to understand how normal cells undergo complex changes leading to cancer.
NCI grant funds study of novel drug for immunotherapy treatment of melanoma
The project builds on the team’s recent development of a PROTAC that showed potential as a small-molecule-based therapy.
